VISTAGEN Trademark

Trademark Overview

On Friday, October 13, 2000, a trademark application was filed for VISTAGEN with the United States Patent and Trademark Office. The USPTO has given the VISTAGEN trademark a serial number of 76146181. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, June 14, 2024. This trademark is owned by VistaGen, Inc.. The VISTAGEN trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Biotechnology services, namely, applied stem cell technologies, functional genomics and rapid drug-lead prioritization for use in pharmaceutical development; predictive toxicology screening for both the pharmaceutical and chemical industries
vistagen

General Information

Serial Number76146181
Word MarkVISTAGEN
Filing DateFriday, October 13, 2000
Status710 - CANCELLED - SECTION 8
Status DateFriday, June 14, 2024
Registration Number2787886
Registration DateTuesday, December 2, 2003
Mark Drawing1 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, February 5, 2002

Trademark Statements

Goods and ServicesBiotechnology services, namely, applied stem cell technologies, functional genomics and rapid drug-lead prioritization for use in pharmaceutical development; predictive toxicology screening for both the pharmaceutical and chemical industries

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, June 14, 2024
Primary Code042
First Use Anywhere DateWednesday, July 21, 1999
First Use In Commerce DateWednesday, July 21, 1999

Trademark Owner History

Party NameVISTAGEN THERAPEUTICS, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressSOUTH SAN FRANCISCO, CA 94080
Party NameVistagen Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameVistagen Therapeutics, Inc.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressBurlingame, CA 940102307
Party NameVistaGen, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMountain View, CA 94043
Party NameVistaGen, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMountain View, CA 94043

Trademark Events

Event DateEvent Description
Wednesday, October 30, 2002SOU EXTENSION 1 FILED
Tuesday, February 20, 2001ASSIGNED TO EXAMINER
Thursday, March 1, 2001APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 16, 2002NOTICE OF PUBLICATION
Tuesday, February 5, 2002PUBLISHED FOR OPPOSITION
Tuesday, April 30, 2002NOA MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, October 30, 2002SOU TEAS EXTENSION RECEIVED
Tuesday, December 2, 2003REGISTERED-PRINCIPAL REGISTER
Wednesday, December 2, 2009TEAS SECTION 8 & 15 RECEIVED
Saturday, December 12, 2009CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, November 19, 2002SOU EXTENSION 1 GRANTED
Monday, April 28, 2003SOU TEAS EXTENSION RECEIVED
Tuesday, April 29, 2003SOU EXTENSION 2 FILED
Friday, May 30, 2003SOU EXTENSION 2 GRANTED
Wednesday, October 8, 2003FAX RECEIVED
Wednesday, October 8, 2003NOTICE OF ALLOWANCE CANCELLED
Wednesday, October 8, 2003Sec. 1(B) CLAIM DELETED
Wednesday, February 6, 2008CASE FILE IN TICRS
Wednesday, June 11, 2014REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Wednesday, June 11, 2014REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Friday, February 19, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, December 12, 2009REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, February 6, 2014TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, February 6, 2014REVIEW OF CORRESPONDENCE COMPLETE - POWER OF ATTORNEY ENTERED
Wednesday, May 21, 2014TEAS SECTION 8 & 9 RECEIVED
Wednesday, June 11, 2014CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, June 11, 2014NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Friday, February 19, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, February 19, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, February 19, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, February 19, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, February 19, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, October 20, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, March 17, 2021AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, October 20, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, October 20, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, December 2, 2022COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, June 14, 2024CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9

Related Keywords

vistagen pharmaceutical predictive development toxicology prioritization screening industries chemical both lead